Cambridge Healthtech Institute’s 14th Annual

Liquid Biopsy

Enabling Precision Oncology for Diagnostics and Drug Development

March 26-27, 2024

 

Liquid biopsy is a maturing technology for early detection of disease, patient stratification and therapy selection, monitoring response to therapy, and detecting disease recurrence. Cambridge Healthtech Institute’s 14th Annual Liquid Biopsy meeting will explore the latest technologies in detection and molecular characterization of CTCs, cell-free circulating tumor DNA (cfDNA), and circulating extracellular RNA, exosomes, and microvesicles, as well as the applications of liquid biopsy in diagnostics and drug development.

 

Coverage will include, but is not limited to:

 

  • Cancer screening and early detection
  • Liquid biopsy for minimal residual disease detection
  • Technology update in liquid biopsy detection and characterization
  • Applications of cell-free DNA and RNA as biomarkers in drug development
  • Liquid biopsy biomarkers for precision oncology
  • Exosomes and microvesicles as biomarkers
  • Predicting immunotherapy response through circulating immune cells
  • Liquid biopsy for companion diagnostics

 

The deadline for priority consideration is September 1, 2023.

 

All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute’s policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

 

Opportunities for Participation:

 

 

For more details on the conference, please contact:

Julia Boguslavsky

Executive Director, Conferences

Cambridge Healthtech Institute

Email: juliab@healthtech.com

 

For sponsorship information, please contact:

 

Companies A-K

Jon Stroup

Sr. Manager, Business Development

Cambridge Healthtech Institute

Phone: (+1) 781-972-5483

Email: jstroup@healthtech.com

 

Companies L-Z

Katelin Fitzgerald

Sr. Manager, Business Development

Cambridge Healthtech Institute

Phone: (+1) 781-247-1824

Email: kfitzgerald@cambridgeinnovationinstitute.com


Register Now
March 26-27, 2024

AI in Precision Medicine

Implementing Precision Medicine

At-Home & Point-of-Care Diagnostics

Liquid Biopsy

Spatial Biology

March 27-28, 2024

Diagnostics Market Access

Rare Disease Genomics and Diagnostics

Infectious Disease Diagnostics

Multi-Cancer Early Detection

Single-Cell Multiomics